Tesamorelin: An FDA-approved GHRH analog that improves metabolism and significantly reduces visceral abdominal fat (Falutz et al., 2007)
Journal of Orthopaedic Research , 2015 Oral and Capsule Dosage Although oral BPC-157 is debated due to potential breakdown in the digestive tract, it has shown unique benefits for gut-related issues such as ulcers, leaky gut, and IBS
Safety advice BPC 157 is not an approved treatment for most medical conditions, and quality and sterility standards vary by supplier
If youre dealing with Crohns disease, IBD, or other GI conditions: Talk with a clinician about evidence-based options first, which may include medications like mesalamine or budesonide as well as new lifestyle and dietary approaches
We thank you for your support!
,